Since MD Anderson’s first CAR T cell therapy clinical trial launched in 2015, we’ve cared for hundreds of patients undergoing CAR T cell therapy. Over the years, we’ve gained valuable insight into this game-changing treatment that trains a patient’s immune system to find and kill cancer cells.
With CAR T cell therapy, T cells that defend the body against disease are extracted from a cancer patient’s blood. The cells are then changed...
